… as having at least two diagnostic claims or one prescription per year of anti-hypertensive,
anti-diabetic, or anti-dyslipidemic medications for the corresponding diagnosis. The outcome …

… In spite of its high prevalence, PAD has often been neglected … terms of myopathy-related
symptoms are greatly outweighed by … diabetes, hypertension, hyperlipidemia and smoking, PAD …

… or ignored by both the patient and the uninformed clinician. … well as treatment for arterial
hypertension, dyslipidemia and … ACE inhibitors were proposed to improve symptoms in patients …

… to patients who had PAD (ie, a prior diagnosis … therapy among patients with PAD versus
those with CHD or cerebrovascular disease (16,17), and suggest that PAD remains a neglected …

… , patients with diabetes greater frequently develop symptoms of … difficult to treat and feature
greater headaches with treatment (in … patients even when aneurysm mortality is disregarded. …

… criteria will neglect the diagnosis of 30%–60% of children with dyslipidemia; therefore, a …
must be assessed in all children/adolescents with signs or symptoms of dyslipidemia [1]. e …

… In general, adherence to all classes of medications improved immediately after discharge
from an admission or consultation for peripheral arterial disease diagnosis, intervention or …

… patients with PAD have more serious symptoms and a worse prognosis, however, neurologists
might neglect the evaluation and management … , diabetes, and dyslipidemia overlap with …

… in peripheral vascular disease symptoms being either ignored or hidden [3, 5]. Early diagnosis
… be given to asymptomatic patients in order to reduce the missed diagnosis rate of PAD. …

… disease (CKD) was defined as an eGFR < 60 ml/min/1.73 m 2 . Peripheral arterial disease
(PAD) was defined based on the finding of carotid and/or lower limb arterial plaques at a …